-
公开(公告)号:US20240131097A1
公开(公告)日:2024-04-25
申请号:US18494658
申请日:2023-10-24
IPC分类号: A61K36/05 , A23L33/105 , A61K8/34 , A61K8/49 , A61K31/055 , A61K31/085 , A61K31/352 , A61P29/00
CPC分类号: A61K36/05 , A23L33/105 , A61K8/347 , A61K8/498 , A61K31/055 , A61K31/085 , A61K31/352 , A61P29/00 , A61K2236/33 , A61K2236/53
摘要: The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.
-
公开(公告)号:US20210161980A1
公开(公告)日:2021-06-03
申请号:US16770558
申请日:2018-12-06
IPC分类号: A61K36/05 , A23L33/105 , A61K31/055 , A61K31/352 , A61K31/085 , A61K8/49 , A61K8/34 , A61P29/00
摘要: The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.
-
公开(公告)号:US20240226211A9
公开(公告)日:2024-07-11
申请号:US18494658
申请日:2023-10-25
IPC分类号: A61K36/05 , A23L33/105 , A61K8/34 , A61K8/49 , A61K31/055 , A61K31/085 , A61K31/352 , A61P29/00
CPC分类号: A61K36/05 , A23L33/105 , A61K8/347 , A61K8/498 , A61K31/055 , A61K31/085 , A61K31/352 , A61P29/00 , A61K2236/33 , A61K2236/53
摘要: The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.
-
-